Argos Therapeutics' IPO

Argos Therapeutics raised a round of funding on February 07, 2014. Investors include Public.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' IPO: